Company profile
YD Bio Limited, a biopharmaceutical company, focuses on regulated diagnostics, life science clinical services, and healthcare product commercialization in the United States and Taiwan. The company offers eye disease treatment products, 3D LensMate Artificial Tears, a natural tear-mimicking lubricant that moisturizes the eyes and relieves dry eye symptoms; 3D LensMate Eye Drops, an ophthalmic solution to alleviate symptoms of dry eye syndrome, including irritation, foreign body sensation, and eye
- CEO
- Dr. Ethan Shen Ph.D.
- Headquarters
- Taipei, Taiwan
- Employees
- 13
- IPO date
- Aug 18, 2025
- Sector
- Healthcare
- Industry
- Biotechnology